Conversation with @RheumKay on his #ACR24 biosimilar talk for @RheumNow https://t.co/LzAIGIG4wu https://t.co/CqSYLpJYAh

• What's The State of Biosimilars?
• https://twitter.com/ericdeinmd/status/1858547083017363622

@drceowen @TheLancetRheum @RheumNow Efficacy in newly diagnosed & established PMR is not necessarily interchangeable different treatment paradigm ?different immunologically Many other diseases have different Rx for induction vs maintenance, early dx vs established. Having said that: doesn't look great for MTX. https://t.co/89lByaYdYq

• https://x.com/drdavidliew/status/1858693549333901326/photo/1

If your pt with #rheumatoid #arthritis is #exhausted - there is a reason #Meta-analysis of 70000 RA Pts #Insomnia is ⬆️4X vs gen population Due to ▶️#pain ▶️#inflammation ▶️#depression 🤷‍♀️ #ACR24 @RheumNow @ACRheum abst#0480

Paraoxonase-1: Possible Biomarker for Progression to RA Dr. Jonathan Kay discusses abstract 0464, Increases in Paraoxonase-1 Activity over Time Associates with Reduced Risk of Incident Inflammatory Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population,… https://t.co/yhcCrrvjxH https://t.co/caf5dUvrOQ

JAK-pot! How fast do DMARDs work? Dr. Mike Putman interviews Dr. Kim Lauper about abstract 0501, How Fast Do JAK-inhibitors, TNF-inhibitors, Abatacept and IL-6 Inhibitors Act in Rheumatoid Arthritis? An International Collaboration of Registers of Rheumatoid Arthritis Patients… https://t.co/GO9EwyrVpV https://t.co/lELE5SJW5i

RheumNow Day 3 Recap: ACR Convergence 2024 Highlights https://t.co/jFIATPKlp7

• Dr. John Cush

What factors are assoc with uptake of newer meds in RA? ➡️Incr use of b/tsDMARDs over 10yrs ➡️Use of newer drugs lower in older ppl, socioeconomic deprived & Asian/Black ppl Could this indicate disparities in access to meds? How can we best address this? Ab2608 #ACR24 @RheumNow

Subsets of lupus arthritis. Kenneth Kalunian @RheumNow #ACR24 https://t.co/ZmHui126zr

• https://x.com/synovialjoints/status/1858619265659670978/photo/1

How often do you ask about #fatigue, #depression & #anxiety in pts with RMDs? Study of >1000 pts found anxiety symptoms in 1/3 pts and significant association between fatigue & anxiety and depression Highlights importance of regular review of MH symptoms Ab2657 #ACR24 @RheumNow https://t.co/0zMOMybrCI

• https://x.com/DrMiniDey/status/1858620697188462887/photo/1